Autoimmune gastrointestinal dysmotility

From WikiMD's WELLNESSPEDIA


Autoimmune gastrointestinal dysmotility
Synonyms AGID
Pronounce N/A
Specialty N/A
Symptoms Nausea, vomiting, abdominal pain, bloating, constipation, diarrhea
Complications Malnutrition, dehydration, intestinal obstruction
Onset Variable
Duration Chronic
Types N/A
Causes Autoimmune disease
Risks Autoimmune disorders, genetic predisposition
Diagnosis Clinical evaluation, antibody testing, gastrointestinal motility studies
Differential diagnosis Irritable bowel syndrome, gastroparesis, chronic intestinal pseudo-obstruction
Prevention N/A
Treatment Immunosuppressive therapy, prokinetic agents, dietary modifications
Medication Corticosteroids, immunomodulators, antiemetics
Prognosis Variable, depends on response to treatment
Frequency Rare
Deaths N/A


A disorder affecting gastrointestinal motility due to autoimmune causes

Autoimmune gastrointestinal dysmotility (AGID) is a rare disorder characterized by abnormal movement of the muscles in the gastrointestinal tract due to an autoimmune response. This condition can affect any part of the gastrointestinal tract, leading to a variety of symptoms and complications.

Pathophysiology[edit]

AGID occurs when the body's immune system mistakenly attacks the nerves and muscles of the gastrointestinal tract. This autoimmune attack can lead to inflammation and damage to the enteric nervous system, which is responsible for controlling the motility of the gastrointestinal tract. The resulting dysmotility can cause either slowed or uncoordinated movement of the digestive tract, affecting the normal process of digestion and absorption.

Symptoms[edit]

The symptoms of AGID can vary widely depending on which part of the gastrointestinal tract is affected. Common symptoms include:

These symptoms can lead to significant discomfort and may severely impact a patient's quality of life.

Diagnosis[edit]

Diagnosing AGID can be challenging due to its rarity and the overlap of symptoms with other gastrointestinal disorders. A comprehensive evaluation typically includes:

Treatment[edit]

Treatment of AGID focuses on managing symptoms and addressing the underlying autoimmune process. Therapeutic approaches may include:

Prognosis[edit]

The prognosis for individuals with AGID varies depending on the severity of the condition and the response to treatment. Early diagnosis and appropriate management can improve outcomes and quality of life for many patients.

Related pages[edit]

Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.